Clinical Trials Browser

Enrolling by invitation × Esophageal Neoplasms × 1 year × Clear all

NCT07371247 2026-01-27

Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy

Phase EARLY_PHASE1 Enrolling by invitation

Gastrointestinal

Esophageal Neoplasms

NCT06603987 2025-11-19

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Phase 1/2 Enrolling by invitation

BreastGastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neurofibrosarcoma

NCT02427269 2025-05-29

BEECAB

Enrolling by invitation

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

NCT06990178 2025-05-25

Adaptive Neoadjuvant Therapy for Esophageal Cancer

Phase NA Enrolling by invitation

Gastrointestinal

Esophageal Neoplasms

NCT05706025 2025-04-06

Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal Cancer

Phase NA Enrolling by invitation

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

NCT06690216 2025-03-30

PD-L1-PET

Phase 1/2 Enrolling by invitation

CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma